Skip to main content
. 2015 Mar 10;32(7):1717–1729. doi: 10.1093/molbev/msv051

Table 1.

Sample of the Genes under Positive Selection in Human and Mouse and Their Parameter Estimates.

Gene Name Positively Selected Sites P-Value of Positively Selected Sites
Genes under positive selection in human
CARD6 264, 346, 382, 750, 767, 805, 818, 903, 916, 937, 998, 1010, and 1031 13 > 0.50, 0 > 0.95, 0 > 0.99
IRF3 119, 129, and 333 3 > 0.50, 0 > 0.95, 0 > 0.99
Genes under positive selection in mouse
Adipoq 25, 27, 29, and 82 4 > 0.50, 0 > 0.95, 0 > 0.99
Atg9a 634 and 662* 2 > 0.50, 1 > 0.95, 0 > 0.99
C1inh 332*, 365, 468, 479 4 > 0.50, 1 > 0.95, 0 > 0.99
C1ra 468, 520, 574, 631, 633, and 634* 6 > 0.50, 1 > 0.95, 0 > 0.99
C6 220, 233, 319, 353, 378, 408, 419, 430, 554, 655, 681, 703, 792, and 930 14 > 0.50, 0 > 0.95, 0 > 0.99
C8b 242*, 263, 278, 383*, and 488 5 > 0.50, 2 > 0.95, 0 > 0.99
Card6 394, 501, and 702 3 > 0.50, 0 > 0.95, 0 > 0.99
Cd200 129 and 177 2 > 0.50, 0 > 0.95, 0 > 0.99
Cd63 31, 118, 143, 184*, 194, and 203 6 > 0.50, 1 > 0.95, 0 > 0.99
Cfh 209, 243, 474, 767, 1005, 1068, 1074, 1104, 1181, and 1227 10 > 0.50, 0 > 0.95, 0 > 0.99
Ecsit 10, 12, 75, 82, 176, 325, 330**, 348, and 371 9 > 0.50, 1 > 0.95, 1 > 0.99
Eif2ak2 136, 155, 181, 182*, 344, and 345 6 > 0.50, 1 > 0.95, 0 > 0.99
F12 45, 65, 166, 243**, and 454 5 > 0.50, 1 > 0.95, 1 > 0.99
Grn 18, 101, 198, 303, 375*, 382, 411, 549, and 597 9 > 0.50, 1 > 0.95, 0 > 0.99
Ifit2 191, 402, and 420 3 > 0.50, 0 > 0.95, 0 > 0.99
Il1rapl2 566, 628, and 666* 3 > 0.50, 1 > 0.95, 0 > 0.99
Il2rb 4, 13, 31, 55, 174, 202, 347*, 402, 418, 491, 496, and 516 12 > 0.50, 1 > 0.95, 0 > 0.99
Il4ra 47, 67, 308, 330, and 626 5 > 0.50, 0 > 0.95, 0 > 0.99
Irf5 232, 259, and 262 3 > 0.50, 0 > 0.95, 0 > 0.99
Lbp 24, 40 and 329 3 > 0.50, 0 > 0.95, 0 > 0.99
Lgals3 22, 92, 94, and 260 4 > 0.50, 0 > 0.95, 0 > 0.99
Lrrfip1 328, 449, 468, 480, and 571 5 > 0.50, 0 > 0.95, 0 > 0.99
Ltb4r1 53, 101, and 175 3 > 0.50, 0 > 0.95, 0 > 0.99
Nlrp14 77, 79*, 186, 212, 219, 254, 257, 263, 272, 281, 284, 291, 294, 315, 319, 333, 358, 393, 415, 424, 453, 465, 530, 549, 552, 553, 584, 613, 657, 679, 684, 685, 687, 696, 782, 810, 814, 829, 846, 848, 902, 908, 912, 931, 953, 956, 958, 978, 982, 984, and 986 51 > 0.50, 0 > 0.95, 0 > 0.99
Nlrp6 22, 25, 72, 77, 80, 81, 85, 96, 101, 113, 114, 190, 192, 251, 260**, 329, 344, 479, 488, 515, 553, 571, 628, 657, 727, 737, 739, 744, 771, 775*, 776, 793, 807, 865, 877, and 880 36 > 0.50, 2 > 0.95, 1 > 0.99
Oas2 55, 56, 139, 171, 199, 211, 221, 298, 481, 549, and 711 11 > 0.50, 0 > 0.95, 0 > 0.99
Plcg2 461 and 594* 2 > 0.50, 1 > 0.95, 0 > 0.99
Ptpn2 166, 206, 319, 321, and 329 5 > 0.50, 0 > 0.95, 0 > 0.99
Rnf31 203, 431, and 1025 3 > 0.50, 0 > 0.95, 0 > 0.99
Sirt1 107, 537, 698, and 701 4 > 0.50, 0 > 0.95, 0 > 0.99
Snap23 109, 133, and 197 3 > 0.50, 0 > 0.95, 0 > 0.99
Stat2 21, 130, 149, 157, 195, 205, 218, 354, 623*, 869, 871, 874, 876, and 877 14 > 0.50, 1 > 0.95, 0 > 0.99
Tcf4 139 1 > 0.50, 0 > 0.95, 0 > 0.99
Tlr3 266, 297, and 603 3 > 0.50, 0 > 0.95, 0 > 0.99
Trif 18, 327, 338, 388, 482, 556, and 711 8 > 0.50, 0 > 0.95, 0 > 0.99

Note.—For each gene the positively selected sites are displayed and the associated posterior probability is indicated as follows: * >0.95, ** >0.99 and no asterisk implies 0.50 < PP < 0.95.